SEC Form 4 · accession 0001553878-15-000013
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Schimmel
Director
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2015 | M | 947 | $27.28 | A | 947 | D | |
| Common Stock | Mar 17, 2015 | S | 947 | $120.00 | D | 0 | D | |
| Common Stock | Mar 19, 2015 | M | 9,053 | $27.28 | A | 9,053 | D | |
| Common Stock | Mar 19, 2015 | S | 9,053 | $120.00 | D | 0 | D | |
| Common StockF2 | holding | — | — | — | 310,996 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $27.28 | Mar 17, 2015 | M | 947 | D | Jun 3, 2009 | Jun 2, 2018 | Common Stock | 947 | 14,053 | D |
| Stock Option (right to buy) | $27.28 | Mar 19, 2015 | M | 9,053 | D | Jun 3, 2009 | Jun 2, 2018 | Common Stock | 9,053 | 5,000 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2014.
- F2The Paul Schimmel Prototype PSP has holdings of 188,601 shares and the reporting person is trustee. The Schimmel Revocable Trust U/A dated 9/6/2000 has holdings of 122,395 shares and the reporting person and his spouse are trustees.